Vietnam's laboratory automation market is expanding steadily as hospitals, diagnostic laboratories and life sciences organisations invest in technologies that improve efficiency, accuracy and testing capacity. With healthcare digitalisation accelerating nationwide, laboratory automation is becoming a key enabler of modern diagnostics and biomedical research.
According to IMARC Group, Vietnam's laboratory automation market reached US$30.4 million in 2025 and is projected to grow to US$50.6 million by 2034. Growth is being driven by increasing investment in healthcare infrastructure, laboratory modernisation and the rapid expansion of the country's pharmaceutical and biotechnology sectors.
Laboratory automation encompasses robotics, software and intelligent laboratory instruments that automate routine workflows, reduce manual intervention and improve diagnostic accuracy. These technologies are increasingly being adopted across clinical diagnostics, genomics, molecular biology, pharmaceutical research, biotechnology and drug discovery.
Several factors are accelerating adoption across Vietnam:
- Government investment in healthcare digitalisation and laboratory infrastructure.
- Expansion of pharmaceutical manufacturing and biotechnology research.
- Increasing adoption of Laboratory Information Management Systems (LIMS).
- Rising demand for molecular diagnostics, genomics and precision medicine.
- Greater use of artificial intelligence (AI) and machine learning to optimise laboratory workflows.
- Growing emphasis on quality assurance and compliance with international laboratory standards.
The market is also benefiting from the increasing adoption of whole laboratory automation and modular automation systems. Hospitals and diagnostic laboratories are investing in automated sample handling, robotic liquid handling, intelligent storage systems and integrated laboratory software to improve turnaround times, reduce human error and manage growing testing volumes. Biotechnology and pharmaceutical companies are similarly deploying automation to accelerate drug discovery, clinical research and quality control processes.
Vietnam's growth reflects broader regional momentum. Across the Asia-Pacific, the laboratory automation market reached US$978.7 million in 2025 and is forecast to grow to US$1.83 billion by 2034%. Globally, the market is expected to increase from US$7.6 billion in 2025 to US$12.9 billion by 2034, driven by rising demand for automation, increasing laboratory workloads and advances in robotics, artificial intelligence and digital laboratory management.
The market is also supported by the continued expansion of Vietnam's clinical laboratory sector. According to IMARC Group, the country's clinical laboratory services market reached US$1.1 billion in 2025 and is forecast to grow to US$1.9 billion by 2034, creating sustained demand for automated testing platforms and laboratory technologies.
Leading suppliers including Thermo Fisher Scientific, Roche Diagnostics, Siemens Healthineers, Beckman Coulter, Agilent Technologies, Bio-Rad Laboratories, Tecan, Eppendorf, Shimadzu and LabWare continue to introduce AI-enabled laboratory software, robotic sample handling systems and integrated automation platforms that improve laboratory productivity and diagnostic performance.
As Vietnam continues to modernise its healthcare system and expand investment in life sciences, laboratory automation is expected to become an increasingly important component of clinical diagnostics, pharmaceutical manufacturing and biomedical research. For suppliers of laboratory equipment, robotics, laboratory informatics, AI-powered software and automation technologies, Vietnam represents a growing market with significant long-term potential.